| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2020 | Dézsi CA, Glezer M, Karpov Y, Brzozowska-Villatte R, Farsang C. Effectiveness of Perindopril/Indapamide Single-Pill Combination in Uncontrolled Patients with Hypertension: A Pooled Analysis of the FORTISSIMO, FORSAGE, ACES and PICASSO Observational Studies. Advances in Therapy. PMID 33150570 DOI: 10.1007/s12325-020-01527-3 | 0.311 | |||
| 2018 | Járai Z, Kolossváry E, Szabó I, Kiss I, Farsang C, Farkas K. [The potential role of oscillometric devices for ankle-brachial index measurements in clinical practice]. Orvosi Hetilap. 159: 176-182. PMID 29376424 DOI: 10.1556/650.2018.30957 | 0.507 | |||
| 2015 | Denardo SJ, Gong Y, Cooper-DeHoff RM, Farsang C, Keltai M, Szirmai L, Messerli FH, Bavry AA, Handberg EM, Mancia G, Pepine CJ. Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy. Plos One. 10: e0122726. PMID 25835002 DOI: 10.1371/journal.pone.0122726 | 0.338 | |||
| 2014 | Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, ... ... Farsang C, et al. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. Journal of Hypertension. 32: 1888-97. PMID 24979303 DOI: 10.1097/Hjh.0000000000000254 | 0.316 | |||
| 2013 | Farsang C. Blood pressure and metabolic efficacy of fixed-dose combination of perindopril and indapamide in everyday practice. Blood Pressure. 22: 3-10. PMID 23163322 DOI: 10.3109/08037051.2012.740787 | 0.368 | |||
| 2012 | Gupta M, Martineau P, Tran T, Després JP, Gaw A, de Teresa E, Farsang C, Gensini GF, Leiter LA, Blanco-Colio LM, Egido J, Langer A. Low-density lipoprotein cholesterol and high-sensitivity C-reactive protein lowering with atorvastatin in patients of South Asian compared with European origin: insights from the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) study. Journal of Clinical Pharmacology. 52: 850-8. PMID 21610204 DOI: 10.1177/0091270011407196 | 0.323 | |||
| 2011 | Grassi G, Cifkova R, Laurent S, Narkiewicz K, Redon J, Farsang C, Viigimaa M, Erdine S, Brambilla G, Bombelli M, Dell'Oro R, Notari M, Mancia G. Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study. European Heart Journal. 32: 218-25. PMID 21047877 DOI: 10.1093/eurheartj/ehq394 | 0.306 | |||
| 2011 | Farkas K, Fábián E, Kolossváry E, Járai Z, Farsang C. Noninvasive assessment of endothelial dysfunction in essential hypertension: Comparison of the forearm microvascular reactivity with flow-mediated dilatation of the brachial artery International Journal of Angiology. 12: 224-228. DOI: 10.1007/S00547-003-1000-8 | 0.567 | |||
| 2009 | Farsang C, Naditch-Brule L, Avogaro A, Ostergren J, Verdecchia P, Maggioni A, van de Borne P, Lins R, Roca-Cusachs A. Where are we with the management of hypertension? From science to clinical practice. Journal of Clinical Hypertension (Greenwich, Conn.). 11: 66-73. PMID 19222670 DOI: 10.1111/J.1751-7176.2008.00066.X | 0.376 | |||
| 2008 | Blanco-Colio LM, MartÃn-Ventura JL, de Teresa E, Farsang C, Gaw A, Gensini G, Leiter LA, Langer A, Martineau P, Egido J. Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFAST. Kidney International. Supplement. S60-3. PMID 19034329 DOI: 10.1038/Ki.2008.514 | 0.338 | |||
| 2008 | Arnold C, Englert Z, Szabadhegyi C, Farsang C. [Digital risk analysis of cardiovascular diseases: new opportunities for the patients. Cardiovascular prevention program in the praxis]. Orvosi Hetilap. 149: 677-84. PMID 18387871 DOI: 10.1556/Oh.2008.28353 | 0.313 | |||
| 2008 | Blanco-Colio LM, MartÃn-Ventura JL, Gómez-Guerrero C, Masramon X, de Teresa E, Farsang C, Gaw A, Gensini G, Leiter LA, Langer A, Egido J. Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk. European Journal of Pharmacology. 586: 259-65. PMID 18374327 DOI: 10.1016/J.Ejphar.2008.02.042 | 0.367 | |||
| 2008 | Arnold C, Englert Z, Szabadhegyi C, Farsang C. Digitalised Risk Analysis of Cardiovascular Diseases: New Possibility to Make Patients Motivated. Use of the Cardiovascular Prevention (CARMEN) Programme in the Practice Hungarian Medical Journal. 2: 407-416. DOI: 10.1556/Hmj.2.2008.28353 | 0.305 | |||
| 2007 | Farsang C. Blood pressure control and response rates with zofenopril compared with amlodipine in hypertensive patients. Blood Pressure. Supplement. 2: 19-24. PMID 18046975 DOI: 10.1080/08038020701561737 | 0.423 | |||
| 2007 | Strasser RH, Puig JG, Farsang C, Croket M, Li J, van Ingen H. A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension. Journal of Human Hypertension. 21: 780-7. PMID 17541390 DOI: 10.1038/sj.jhh.1002220 | 0.307 | |||
| 2007 | Blanco-Colio LM, MartÃn-Ventura JL, de Teresa E, Farsang C, Gaw A, Gensini G, Leiter LA, Langer A, Martineau P, Egido J. Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration. American Heart Journal. 153: 881-8. PMID 17452168 DOI: 10.1016/J.Ahj.2007.02.029 | 0.339 | |||
| 2007 | Blanco-Colio LM, MartÃn-Ventura JL, de Teresa E, Farsang C, Gaw A, Gensini G, Leiter LA, Langer A, Martineau P, Hérnandez G, Egido J. Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST. Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 168-74. PMID 17053166 DOI: 10.1161/01.Atv.0000250616.26308.D7 | 0.35 | |||
| 2006 | Rosei EA, Salvetti M, Farsang C. European Society of Hypertension Scientific Newsletter: treatment of hypertensive urgencies and emergencies. Journal of Hypertension. 24: 2482-5. PMID 17082737 DOI: 10.1097/Hjh.0B013E328010B8F3 | 0.382 | |||
| 2005 | Farkas K, Nemcsik J, Kolossváry E, Járai Z, Borvendég J, Nádory E, Farsang C, Kiss I. [Noninvasive assessment of endothelial function in hemodialyzed hypertensive patients by laser Doppler flowmetry]. Orvosi Hetilap. 146: 2589-94. PMID 16468613 | 0.608 | |||
| 2005 | Kolossváry E, Kollár A, Pintér H, Erényi E, Kiséry I, Péter H, Farkas K, Mogán L, Farsang C, Kiss I. Bilateral axillobrachial and external carotid artery manifestation of giant cell arteritis: important role of color duplex ultrasonography in the diagnosis. International Angiology : a Journal of the International Union of Angiology. 24: 202-5. PMID 15997226 | 0.513 | |||
| 2005 | Farkas K, Nemcsik J, Kolossváry E, Járai Z, Nádory E, Farsang C, Kiss I. Impairment of skin microvascular reactivity in hypertension and uraemia. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 20: 1821-7. PMID 15985514 DOI: 10.1093/Ndt/Gfh944 | 0.638 | |||
| 2005 | Kiss I, Farsang C, Rodicio JL. Treatment of hypertension in dialysed patients. Journal of Hypertension. 23: 222-6. PMID 15643149 DOI: 10.1097/00004872-200501000-00038 | 0.397 | |||
| 2005 | Szirmai LA, Arnold C, Farsang C. Improving control of hypertension by an integrated approach -- results of the 'Manage it well!' programme. Journal of Hypertension. 23: 203-11. PMID 15643143 DOI: 10.1097/00004872-200501000-00031 | 0.366 | |||
| 2004 | Farkas K, Kolossváry E, Járai Z, Nemcsik J, Farsang C. Non-invasive assessment of microvascular endothelial function by laser Doppler flowmetry in patients with essential hypertension. Atherosclerosis. 173: 97-102. PMID 15177128 DOI: 10.1016/J.Atherosclerosis.2003.11.015 | 0.613 | |||
| 2004 | Finta E, Alföldi S, László F, Nemcsik J, Kun E, Eröss A, Farsang C, Kiss I. EFFECT OF RILMENIDINE ON HEART RATE VARIABILITY AND BAROREFLEX SENSITIVITY IN HYPERTENSIVE PATIENTS Journal of Hypertension. 22: S206. DOI: 10.1097/00004872-200406002-00718 | 0.348 | |||
| 2004 | Farkas K, Nemcsik J, Kolossváry E, Járai Z, Borvendég J, Farsang CS, Kiss I. SKIN MICROVASCULAR REACTIVITY IN HYPERTENSIVE PATIENTS WITH AND WITHOUT END STAGE RENAL DISEASE Journal of Hypertension. 22: S194. DOI: 10.1097/00004872-200406002-00672 | 0.56 | |||
| 2003 | Kjeldsen SE, Erdine S, Farsang C, Sleight P, Mancia G. 1999 WHO/ISH Hypertension Guidelines--highlights & ESH Update. Blood Pressure. 12: 181-2. PMID 12875481 DOI: 10.1097/00004872-200112000-00026 | 0.383 | |||
| 2002 | Farsang C, Sleight P. Isolated systolic hypertension: cardiovascular risk and treatment benefits. Journal of Hypertension. 19: 2279-81. PMID 11725174 DOI: 10.1097/00004872-200112000-00023 | 0.381 | |||
| 2001 | Kjeldsen SE, Os I, Farsang C, Mallion JM, Hansson L, Sleight P. Treatment of hypertension in patients with type-2 diabetes mellitus. Journal of Hypertension. 18: 1345-6. PMID 10994767 DOI: 10.1097/00004872-200018090-00023 | 0.313 | |||
| 2000 | Farsang C, Garcia-Puig J, Niegowska J, Baiz AQ, Vrijens F, Bortman G. The efficacy and tolerability of losartan versus atenolol in patients with isolated systolic hypertension. Losartan ISH Investigators Group. Journal of Hypertension. 18: 795-801. PMID 10872566 DOI: 10.1097/00004872-200018060-00019 | 0.363 | |||
| 2000 | Hansson L, Lithell H, Skoog I, Bánki CM, Breteler M, Castaigne A, Correia M, Degaute J, Elmfeldt D, Engedal K, Farsang C, Ferro J, Hachinski V, Hofman A, James OFW, et al. Study on COgnition and Prognosis in the Elderly (SCOPE): Baseline Characteristics Blood Pressure. 9: 146-151. DOI: 10.1080/080370500453483999 | 0.322 | |||
| 1999 | Hansson L, Lithell H, Skoog I, Baro F, Bánki CM, Breteler M, Carbonin PU, Castaigne A, Correia M, Degaute JP, Elmfeldt D, Engedal K, Farsang C, Ferro J, Hachinski V, et al. Study on COgnition and Prognosis in the Elderly (SCOPE). Blood Pressure. 8: 177-83. PMID 10595696 DOI: 10.1080/080370599439715 | 0.347 | |||
| 1999 | FARSANG C. Losartan treatment of patients with isolated systolic hypertension. American Journal of Hypertension. 12: 140. DOI: 10.1016/S0895-7061(99)80498-1 | 0.393 | |||
| 1991 | Kiss I, Farsang C. Nifedipine-prazosin interaction in patients with essential hypertension. Cardiovascular Drugs and Therapy. 3: 413-5. PMID 2487537 DOI: 10.1007/Bf01858112 | 0.312 | |||
| 1990 | Kiss I, Lázár A, Paulin F, Farsang C. Retrospective analysis of clinical data of normotensive and hypertensive pregnant women and their newborns. Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 7: S336-7. PMID 2632737 DOI: 10.1097/00004872-198900076-00164 | 0.337 | |||
| 1984 | Farsang C, Varga K, Vajda L, Alföldi S, Kapocsi J. Effects of clonidine and guanfacine in essential hypertension. Clinical Pharmacology and Therapeutics. 36: 588-94. PMID 6386275 DOI: 10.1038/Clpt.1984.226 | 0.346 | |||
| 1980 | Farsang C, Debreczeni L, Kerényi A, Takács L. Postocclusion hyperemia in the isolated fibrillating blood-perfused dog heart. Cardiology. 65: 65-84. PMID 7363285 DOI: 10.1159/000170797 | 0.341 | |||
| 1979 | Farsang C, Debreczeni L, Kerényi A, Takács L. Effect of phenoxybenzamine and propranolol on myocardial reactive hyperaemia in fibrillating canine heart. Pflugers Archiv : European Journal of Physiology. 379: 223-8. PMID 223117 DOI: 10.1007/Bf00581425 | 0.301 | |||
| Low-probability matches (unlikely to be authored by this person) | |||||
| 2011 | Farsang C. Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk. Vascular Health and Risk Management. 7: 605-22. PMID 22102784 DOI: 10.2147/VHRM.S23468 | 0.292 | |||
| 2006 | Finta E, Laude D, Alföldi S, Farsang C, Elghozi JL. Effects of rilmenidine on 24-h rhythmicity of blood pressure and spontaneous baroreflex sensitivity in essential hypertensive subjects. Journal of Hypertension. 24: 1619-25. PMID 16877965 DOI: 10.1097/01.hjh.0000239298.63377.db | 0.29 | |||
| 2003 | Farsang C, Lengyel M, Borbás S, Zorándi A, Dienes BS. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS). Current Medical Research and Opinion. 19: 205-17. PMID 12803735 DOI: 10.1185/030079903125001659 | 0.287 | |||
| 2006 | Farsang C, Narkiewicz K, Kiowski W, Ambrosioni E, Vigimaa M. Hypertension Excellence Centres of the European Society of Hypertension Journal of Hypertension. 24: 787. DOI: 10.1097/01.HJH.0000217866.43111.DC | 0.283 | |||
| 1986 | Farsang C, Péter M, Balás-Éltes A, Fehér J. Prazosin Improves Atherogenic Index and Inhibits the Deleterious Effect of Dihydrochlorothiazide in Patients with Essential Hypertension Journal of Cardiovascular Pharmacology. 10: S240-S243. DOI: 10.1097/00005344-198609002-00040 | 0.281 | |||
| 2007 | Brodszky V, Nagy V, Farsang C, Kárpáti K, Gulácsi L. [The efficacy of indapamide in different cardiovascular outcome--meta-analysis]. Orvosi Hetilap. 148: 1203-11. PMID 17588853 DOI: 10.1556/Hmj.2.2008.2.28046 | 0.279 | |||
| 1979 | Farsang C, Kerényi A, Takács L. Regulation of myocardial oxygen consumption by perfusion pressure in isolated fibrillating canine heart. Pflugers Archiv : European Journal of Physiology. 380: 211-3. PMID 573460 DOI: 10.1007/Bf00582898 | 0.277 | |||
| 1993 | Farsang C, Kiss I, Kapocsi J, Török E, Maklári E. Antihypertensive effect of the calcium antagonist isradipine and lipid profile. American Journal of Hypertension. 6: 107S-109S. PMID 8466717 DOI: 10.1093/Ajh/6.3.107S | 0.276 | |||
| 2007 | Martineau P, Gaw A, de Teresa E, Farsang C, Gensini GF, Leiter LA, Langer A. Effect of individualizing starting doses of a statin according to baseline LDL-cholesterol levels on achieving cholesterol targets: the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study. Atherosclerosis. 191: 135-46. PMID 16643923 DOI: 10.1016/J.Atherosclerosis.2006.03.019 | 0.276 | |||
| 2002 | Kjeldsen SE, Erdine S, Farsang C, Sleight P, Mancia G. 1999 WHO/ISH Hypertension Guidelines--highlights & ESH update. Journal of Hypertension. 20: 153-5. PMID 11791039 | 0.275 | |||
| 2016 | Denardo SJ, Gong Y, Cooper-DeHoff RM, Farsang C, Keltai M, Szirmai L, Messerli FH, Bavry AA, Handberg EM, Mancia G, Pepine CJ. Correction: Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy. Plos One. 11: e0157212. PMID 27258057 DOI: 10.1371/journal.pone.0157212 | 0.274 | |||
| 2008 | Kjeldsen SE, Naditch-Brule L, Perlini S, Zidek W, Farsang C. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. Journal of Hypertension. 26: 2064-70. PMID 18806632 DOI: 10.1097/HJH.0b013e32830c45c3 | 0.273 | |||
| 2004 | Farsang C, Alföldi S, Barna I, Finta PE, Kapocsi J, Kishegyi J, Kiss I, Lamm G, Ostör E, Tamás F. Effective control of hypertension: a project of the Hungarian Society of Hypertension, baseline data. Journal of Human Hypertension. 18: 591-4. PMID 15002002 DOI: 10.1038/Sj.Jhh.1001695 | 0.27 | |||
| 1984 | Farsang C, Kapocsi J, Vajda L, Varga K, Malisak Z, Fekete M, Kunos G. Reversal by naloxone of the antihypertensive action of clonidine: involvement of the sympathetic nervous system. Circulation. 69: 461-7. PMID 6362905 DOI: 10.1161/01.CIR.69.3.461 | 0.269 | |||
| 1983 | Farsang C, Kapocsi J, Juhasz I, Kunos G. Possible involvement of an endogenous opioid in the antihypertensive effect of clonidine in patients with essential hypertension. Circulation. 66: 1268-72. PMID 6291802 DOI: 10.1161/01.CIR.66.6.1268 | 0.269 | |||
| 2018 | Dézsi CA, Farsang C. Efficacy and Tolerability of Fixed-Dose Combination Perindopril/Indapamide in Hypertensive Patients with a History of Stroke or Transient Ischemic Attack: PICASSO Trial. Advances in Therapy. PMID 29748913 DOI: 10.1007/s12325-018-0705-1 | 0.266 | |||
| 2004 | Krum H, Carson P, Farsang C, Maggioni AP, Glazer RD, Aknay N, Chiang YT, Cohn JN. Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT. European Journal of Heart Failure. 6: 937-45. PMID 15556056 DOI: 10.1016/J.Ejheart.2004.09.005 | 0.265 | |||
| 1987 | Kapocsi J, Farsang C, Vizi ES. Prazosin partly blocks clonidine-induced hypotension in patients with essential hypertension European Journal of Clinical Pharmacology. 32: 331-334. PMID 3038563 DOI: 10.1007/BF00543963 | 0.26 | |||
| 2000 | Farsang C, DeChatel R, Kovacs P, Preda I, Illyes M, Juhasz A, Karanyi Z. ENALAPRIL IN ISOLATED SYSTOLIC HYPERTENSION Journal of Hypertension. 18: S164. DOI: 10.1097/00004872-200006001-00562 | 0.26 | |||
| 1984 | Farsang C, Varga K, Vajda L, Kapocsi J, Balás-Eltes A, Kunos G. Beta-endorphin contributes to the antihypertensive effect of clonidine in a subset of patients with essential hypertension. Neuropeptides. 4: 293-302. PMID 6089027 DOI: 10.1016/0143-4179(84)90003-9 | 0.26 | |||
| 2024 | Nemcsik J, Takács J, Pásztor D, Farsang C, Simon A, Páll D, Torzsa P, Dolgos S, Koller A, Habony N, Járai Z. Frequency of office blood pressure measurements and the seasonal variability of blood pressure: results of the Hungarian Hypertension Registry. Blood Pressure. 33: 2337170. PMID 38581160 DOI: 10.1080/08037051.2024.2337170 | 0.256 | |||
| 2008 | Farsang C, Naditch-Brule L, Perlini S, Zidek W, Kjeldsen SE. Inter-regional comparisons of the prevalence of cardiometabolic risk factors in patients with hypertension in Europe: the GOOD survey. Journal of Human Hypertension. 23: 316-24. PMID 19005476 DOI: 10.1038/jhh.2008.136 | 0.255 | |||
| 1981 | Farsang C, Juhász I, Kapocsi J, Vajda L, Székács B. Effect of prazosin and oxprenolol on plasma renin activity and blood pressure in patients with essential hypertension. Cardiology. 67: 164-71. PMID 7023672 DOI: 10.1159/000173239 | 0.254 | |||
| 2007 | Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, ... ... Farsang C, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal. 28: 1462-536. PMID 17562668 DOI: 10.1093/Eurheartj/Ehm236 | 0.251 | |||
| 2011 | Farsang C. ANTIHYPERTENSIVE AND METABOLIC EFFECTS AND SAFETY OF HIGH-DOSE PERINDOPRIL/INDAPAMIDE IN HYPERTENSIVES: PERINDOPRIL/INDAPAMIDE COMBINATION BLOOD PRESSURE REDUCTION (PICASSO) STUDY Journal of Hypertension. 29: e268. DOI: 10.1097/00004872-201106001-00750 | 0.249 | |||
| 2004 | Ingino C, Farsang C, Laucevicius A, Bergovec M. An open-label study investigating the efficacy and safety of 12-96 weeks of telmisartan treatment in patients with hypertension. The Journal of International Medical Research. 31: 561-74. PMID 14708422 DOI: 10.1177/147323000303100613 | 0.249 | |||
| 2016 | Laurent S, Parati G, Chazova I, Sirenko Y, Erglis A, Laucevicius A, Farsang C. [PP.13.13] ONE MONTH BLOOD PRESSURE LOWERING EFFICACY RESULTS OF A NOVEL FIRST-LINE TREATMENT IN HYPERTENSION Journal of Hypertension. 34: e194. DOI: 10.1097/01.hjh.0000491885.32512.3b | 0.243 | |||
| 1994 | Farsang C, Kapocsi J, Kiss I, Török E, Kerkovits G, Holló J, Jávor T. Hungarian Isradipine Study (HIS): long-term (3-year) effects on blood pressure and plasma lipids. American Journal of Hypertension. 7: 56S-60S. PMID 7946181 DOI: 10.1093/ajh/7.7.56S | 0.242 | |||
| 2006 | Rosei EA, Salvetti M, Farsang C. Treatment of hypertensive urgencies and emergencies. Blood Pressure. 15: 255-6. PMID 17078189 | 0.237 | |||
| 2012 | Perlini S, Naditch-Brule L, Farsang C, Zidek W, Kjeldsen SE. Pulse pressure and heart rate in patients with metabolic syndrome across Europe: insights from the GOOD survey. Journal of Human Hypertension. 27: 412-6. PMID 23235366 DOI: 10.1038/jhh.2012.61 | 0.234 | |||
| 2000 | Kiss I, Császár A, Kerkovits L, Takács G, Szalay C, Romics L, Farsang C. GENETIC RISK OF ANGIOTENSIN-CONVERTING ENZYME GENE I/D AND ANGIOTENSIN II RECEPTOR TYPE- Journal of Hypertension. 18: S185-S186. DOI: 10.1097/00004872-200006001-00643 | 0.234 | |||
| 1983 | Farsang C, Vajda L, Kapocsi J, Malisák Z, Alföldi S, Varga K, Juhász I, Kunos G. Diurnal rhythm of beta endorphin in normotensive and hypertensive patients: the effect of clonidine. The Journal of Clinical Endocrinology and Metabolism. 56: 865-7. PMID 6300170 DOI: 10.1210/jcem-56-4-865 | 0.227 | |||
| 2007 | Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, ... ... Farsang C, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension. 25: 1105-87. PMID 17563527 DOI: 10.1097/HJH.0b013e3281fc975a | 0.227 | |||
| 2013 | Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, ... ... Farsang C, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal. 34: 2159-219. PMID 23771844 DOI: 10.1093/eurheartj/eht151 | 0.227 | |||
| 1988 | Farsang C, Varga K, Kapocsi J. Prazosin-clonidine and prazosin-guanfacine interactions in hypertension Pharmacological Research Communications. 20: 85-86. DOI: 10.1016/S0031-6989(88)80653-2 | 0.225 | |||
| 2016 | Simonyi G, Ferenci T, Alföldi S, Farsang C. Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence. The Journal of International Medical Research. PMID 27435392 DOI: 10.1177/0300060516645004 | 0.22 | |||
| 2008 | Menne J, Farsang C, Deák L, Klebs S, Meier M, Handrock R, Sieder C, Haller H. Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial. Journal of Hypertension. 26: 1860-7. PMID 18698222 DOI: 10.1097/HJH.0b013e32830508aa | 0.22 | |||
| 2004 | Papademetriou V, Farsang C, Elmfeldt D, Hofman A, Lithell H, Olofsson B, Skoog I, Trenkwalder P, Zanchetti A. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE). Journal of the American College of Cardiology. 44: 1175-80. PMID 15364316 DOI: 10.1016/J.Jacc.2004.06.034 | 0.217 | |||
| 2000 | Tornóci L, Farsang C, Östör E, Kishegyi J, Lamm G. ANALYSIS OF MONOTHERAPY DRUG TREATMENT OF HYPERTENSION IN HUNGARIAN FAMILY PRACTICES. THE EFFECTIVE CONTROL OF HYPERTENSION PROJECT (EHCP) Journal of Hypertension. 18: S35. DOI: 10.1097/00004872-200006001-00106 | 0.217 | |||
| 2007 | Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, ... ... Farsang C, et al. [ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Revista Espaã±Ola De CardiologãA. 60: 968.e1-94. PMID 17915153 DOI: 10.1157/13109650 | 0.212 | |||
| 2018 | Dézsi CA, Farsang C, Villatte R, Karpov Y, Glezer M. A11531 Effectiveness of perindopril/indapamide single-pill combination in uncontrolled hypertensive patients Journal of Hypertension. 36: e202. DOI: 10.1097/01.hjh.0000548824.15524.dd | 0.211 | |||
| 1988 | Kiss I, Illyés M, Gäti I, Farsang C. 147 Treatment of pregnant hypertensive patients with nifedipine and alpha-methyldopa Journal of Hypertension. 6: S755. DOI: 10.1097/00004872-198812040-00364 | 0.21 | |||
| 2014 | Farsang C. Efficacy and tolerability of fixed-dose combination of perindopril/indapamide in type 2 diabetes mellitus: PICASSO trial. Advances in Therapy. 31: 333-44. PMID 24554346 DOI: 10.1007/s12325-014-0107-y | 0.21 | |||
| 2015 | Laurent S, Parati G, Chazova I, Sirenko Y, Erglis A, Laucevicius A, Farsang C. Randomized evaluation of a novel, fixed-dose combination of perindopril 3.5 mg/amlodipine 2.5 mg as a first-step treatment in hypertension. Journal of Hypertension. 33: 653-61; discussion 6. PMID 25479022 DOI: 10.1097/HJH.0000000000000440 | 0.209 | |||
| 2007 | Viigimaa M, Farsang C, Kjeldsen SE, Narkiewicz K, Mancia G. ESH Hypertension Excellence Centres: a new strategy to combat an old foe Journal of Hypertension. 25: 1744-1748. DOI: 10.1097/HJH.0b013e328286266e | 0.208 | |||
| 2005 | van Zwieten PA, Farsang C. Combination of antihypertensive drugs from a historical perspective. Blood Pressure. 14: 72-9. PMID 16036483 DOI: 10.1080/08037050510008922 | 0.206 | |||
| 1987 | Alföldi A, Farsang C. Metoclopramide decreases baroreflex sensitivity in patients with essential hypertension. Life Sciences. 40: 1469-72. PMID 3561160 DOI: 10.1016/0024-3205(87)90378-X | 0.205 | |||
| 2005 | Kiss I, Farsang C. [Practical guide-lines for the treatment of hypertension]. Orvosi Hetilap. 146: 267-74. PMID 15779815 | 0.196 | |||
| 2009 | Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Pressure. 18: 308-47. PMID 20001654 DOI: 10.3109/08037050903450468 | 0.195 | |||
| 2009 | Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Journal of Hypertension. 27: 2121-58. PMID 19838131 DOI: 10.1097/HJH.0b013e328333146d | 0.195 | |||
| 1980 | Farsang C, Kunos G. Naloxone reverses the antihypertensive effect of clonidine. British Journal of Pharmacology. 67: 161-4. PMID 227508 DOI: 10.1111/j.1476-5381.1979.tb08661.x | 0.193 | |||
| 2018 | Farsang C, Dézsi CA, Villatte R, Glezer M, Karpov Y. A11586 Effectiveness of perindopril/indapamide single-pill combination in uncontrolled hypertensive patients with diabetes Journal of Hypertension. 36: e203. DOI: 10.1097/01.hjh.0000548829.46018.3e | 0.189 | |||
| 2018 | Farsang C. [Prof. Dr. István Kiss (1952-2018)]. Orvosi Hetilap. 159: 1241. PMID 30032663 DOI: 10.1556/650.2018.Ho2607 | 0.183 | |||
| 1982 | Ramirez-Gonzalez MD, Farsang C, Tchakarov L, Kunos G. Opiate antagonists reverse the centrally mediated antihypertensive action of propranolol in spontaneously hypertensive rats. European Journal of Pharmacology. 81: 167-70. PMID 6288400 DOI: 10.1016/0014-2999(82)90619-7 | 0.178 | |||
| 2014 | Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, ... ... Farsang C, et al. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence. Journal of Hypertension. 32: 1741-50. PMID 24979302 DOI: 10.1097/Hjh.0000000000000253 | 0.175 | |||
| 2021 | Farsang C, Dézsi CA, Brzozowska-Villatte R, De Champvallins M, Glezer M, Karpov Y. Beneficial Effects of a Perindopril/Indapamide Single-Pill Combination in Hypertensive Patients with Diabetes and/or Obesity or Metabolic Syndrome: A Post Hoc Pooled Analysis of Four Observational Studies. Advances in Therapy. PMID 33630277 DOI: 10.1007/s12325-021-01619-8 | 0.167 | |||
| 2018 | Dézsi CA, Glezer M, Villatte R, Karpov Y, Farsang C. A11512 Effectiveness of perindopril/indapamide single-pill combination in uncontrolled hypertensive obese patients Journal of Hypertension. 36: e202. DOI: 10.1097/01.hjh.0000548823.07901.3a | 0.164 | |||
| 2008 | Farsang C. [St. Imre Hospital forever . . . Interview with Dr. Csaba Farsang]. Orvosi Hetilap. 149: 1247. PMID 18565822 DOI: 10.1556/Oh.2008.I26 | 0.164 | |||
| 2006 | Blanco-Colio L, Martin-Ventura J, De Teresa E, Farsang C, Gaw A, Gensini G, Leiter L, Langer A, Martineau P, Egido J. Th-P16:356 Atorvastatin diminished ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers (AIM) study Atherosclerosis Supplements. 7: 572. DOI: 10.1016/S1567-5688(06)82314-7 | 0.162 | |||
| 2006 | Kárpáti K, Brodszky V, Farsang C, Jermendy G, Vándorfi G, Zámolyi K, Gulácsi L. [The effectiveness of carvedilol in heart failure]. Orvosi Hetilap. 147: 1931-7. PMID 17111685 | 0.158 | |||
| 2016 | Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Guan TR, Zhang Y, Zhang X, ... ... Farsang C, et al. Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. Journal of Hypertension. PMID 26780185 DOI: 10.1097/Hjh.0000000000000853 | 0.154 | |||
| 2009 | Zidek W, Naditch-Brûlé L, Perlini S, Farsang C, Kjeldsen SE. Blood pressure control and components of the metabolic syndrome: the GOOD survey. Cardiovascular Diabetology. 8: 51. PMID 19754934 DOI: 10.1186/1475-2840-8-51 | 0.154 | |||
| 2011 | Brambilla G, Seravalle G, Cifkova R, Laurent S, Narkiewicz K, Redon J, Farsang C, Bombelli M, Giannattasio C, Mancial G, Grassi G. METABOLIC PROFILE, PATTERNS OF METABOLIC CONTROL BY TREATMENT AND RELATIONSHIPS WITH BLOOD PRESSURE VALUES IN PATIENTS FROM CENTRAL AND EASTERN EUROPEAN COUNTRIES: THE BP-CARE METABOLIC STUDY Journal of Hypertension. 29: e5-e6. DOI: 10.1097/00004872-201106001-00015 | 0.153 | |||
| 2004 | Lengyel M, Farsang C, Dénes M, Kiss T. [Use of anticoagulant therapy in non-valvular atrial fibrillation. Analysis of a Hungarian cohort]. Orvosi Hetilap. 145: 517-20. PMID 15085590 | 0.145 | |||
| 2015 | Farsang C. O60. Treatment of hypertension in pregnancy Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health. 5: 223. DOI: 10.1016/J.PREGHY.2015.07.036 | 0.145 | |||
| 2006 | Blanco-Colio L, Martin-Ventura J, De Teresa E, Farsang C, Gaw A, Gensini G, Leiter L, Langer A, Martineau P, Egido J. Th-P16:413 Atorvastatin decreased criculating CD40 ligand levels in subjects at highe cardiovascular risk Atorvastatin on inflammatory markers (aim) study Atherosclerosis Supplements. 7: 584. DOI: 10.1016/S1567-5688(06)82371-8 | 0.138 | |||
| 2004 | Cifkova R, Erdine S, Fagard R, Farsang C, Heagerty AM, Kiowski W, Kjeldsen S, Lüscher T, Mallion JM, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, van Zwieten P, et al. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. Journal of Hypertension. 21: 1779-86. PMID 14508180 DOI: 10.1097/01.HJH.0000084773.37215.1B | 0.135 | |||
| 2001 | Farsang C, Kawecka-Jaszcz K, Langan J, Maritz F, Zannad F. Antihypertensive Effects and Tolerability of Candesartan Cilexetil Alone and in Combination with Amlodipine Clinical Drug Investigation. 21: 17-23. DOI: 10.2165/00044011-200121010-00003 | 0.132 | |||
| 1989 | Alföldi A, Kárteszi M, Simkó K, Farsang C. Dopaminergic-opioidergic interaction is reflected by changes in pituitary hormone secretion in patients with essential hypertension. Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 6: S387-8. PMID 2977177 DOI: 10.1097/00004872-198812040-00121 | 0.129 | |||
| 2003 | LENGYEL M, FARSANG C, ZORANDI A. 157 Prognosis of systolic and diastolic heart failure in the elderly European Journal of Echocardiography. 4: S12. DOI: 10.1016/S1525-2167(03)90610-X | 0.124 | |||
| 2007 | Farsang C, Athyros V, Gaw A. A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-2) study. Current Medical Research and Opinion. 23: 1945-56. PMID 17626713 DOI: 10.1185/030079907X223242 | 0.118 | |||
| 1984 | Kunos G, Newman F, Farsang C, Ungar W. Thyrotropin releasing hormone and naloxone attenuate the antihypertensive action of central alpha 2-adrenoceptor stimulation through different mechanisms. Endocrinology. 115: 2481-3. PMID 6094160 DOI: 10.1210/endo-115-6-2481 | 0.115 | |||
| 2008 | Leiter LA, Martineau P, de Teresa E, Farsang C, Gaw A, Gensini G, Langer A. How to reach LDL targets quickly in patients with diabetes or metabolic syndrome. The Journal of Family Practice. 57: 661-8. PMID 18842192 | 0.113 | |||
| 1975 | Takács L, Debreczeni LA, Farsang C. Circulation in rats with Guérin carcinoma. Journal of Applied Physiology. 38: 696-701. PMID 1141100 DOI: 10.1152/jappl.1975.38.4.696 | 0.108 | |||
| 1981 | FARSANG C, KUNOS G, Brown BR. Naloxone Reverses the Antihypertensive Effect of Clonidine Survey of Anesthesiology. 25: 6. DOI: 10.1097/00132586-198102000-00008 | 0.104 | |||
| 2003 | Tonstad S, Farsang C, Klaene G, Lewis K, Manolis A, Perruchoud AP, Silagy C, van Spiegel PI, Astbury C, Hider A, Sweet R. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. European Heart Journal. 24: 946-55. PMID 12714026 DOI: 10.1016/S0195-668X(03)00003-4 | 0.103 | |||
| 2010 | Gensini GF, Gori AM, Dilaghi B, Rostagno C, Gaw A, Blanco-Colio LM, de Teresa E, Egido J, Farsang C, Leiter LA, Martineau P, Nozza A, Langer A. Effect of atorvastatin on circulating hsCRP concentrations: a sub-study of the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study. International Journal of Cardiology. 142: 257-64. PMID 19217176 DOI: 10.1016/j.ijcard.2008.12.213 | 0.097 | |||
| 2003 | LENGYEL M, FARSANG C, ZORANDI A. 133 Pulmonary venous flow pattern indicates diastolic dysfunction in atrial fibrillation European Journal of Echocardiography. 4: S7. DOI: 10.1016/S1525-2167(03)90586-5 | 0.097 | |||
| 1981 | Kunos G, Farsang C, Ramirez-Gonzales MD. beta-Endorphin: possible involvement in the antihypertensive effect of central alpha-receptor activation. Science (New York, N.Y.). 211: 82-4. PMID 6108611 DOI: 10.1126/science.6108611 | 0.094 | |||
| 2007 | Gupta M, de Teresa E, Farsang C, Gaw A, Gensini G, Leiter L, Martineau P, Langer A. PO23-732 LDL-C AND CRP LOWERING WITH ATORVASTATIN IN SOUTH ASIANS AND CAUCASIANS: INSIGHTS FROM THE ACTFAST STUDY Atherosclerosis Supplements. 8: 195. DOI: 10.1016/S1567-5688(07)71742-7 | 0.087 | |||
| 2003 | Tonstad S, Farsang C, Klaene G. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicenter, randomized study Acc Current Journal Review. 12: 28-29. DOI: 10.1016/J.Accreview.2003.08.038 | 0.072 | |||
| 1987 | Kapocsi J, Zimanyi I, Farsang C, Vizi ES. Presynaptic alpha 2-adrenoceptors exclusively sensitive to agonists of phenylethylamine structure on the sympathetic nerves of the human gall bladder artery. Neuroscience Research. 4: 413-8. PMID 2823195 DOI: 10.1016/0168-0102(87)90006-X | 0.072 | |||
| 2003 | LENGYEL M, BORBAS S, FARSANG C, ZORANDI A. 514 Left ventricular hypertrophy regression is persistent on antihypertensive therapy for 3 years European Journal of Echocardiography. 4: S59. DOI: 10.1016/S1525-2167(03)90796-7 | 0.071 | |||
| 1997 | FARSANG C. H13 Antihypertensive effects and tolerability of candesartan cilexetil, amlodipine and their combination American Journal of Hypertension. 10: 80A. DOI: 10.1016/S0895-7061(97)88934-0 | 0.07 | |||
| 1999 | Farsang C, Kapocsi J. Imidazoline receptors: from discovery to antihypertensive therapy (facts and doubts). Brain Research Bulletin. 49: 317-31. PMID 10452352 DOI: 10.1016/S0361-9230(99)00057-X | 0.065 | |||
| 2004 | de Teresa E, Farsang C, Gaw A, Gensini G, Leiter L, Martineau P, Lange A. M.500 Achieve cholesterol targets fast with atorvastatin stratified titration: The actfast study Atherosclerosis Supplements. 5: 115. DOI: 10.1016/S1567-5688(04)90498-4 | 0.064 | |||
| 2004 | van Zwieten PA, Farsang C. Beneficial combinations of two or more antihypertensive agents. Blood Pressure. 13: 62-3. PMID 15083643 | 0.063 | |||
| 2003 | van Zwieten PA, Farsang C. Interactions between antihypertensive agents and other drugs. Blood Pressure. 12: 351-2. PMID 14763670 | 0.052 | |||
| 1988 | Varga K, Simko K, Kapocsi J, Farsang C. Chronic clonidine treatment and endogenous opioid mechanisms Pharmacological Research Communications. 20: 127-128. DOI: 10.1016/S0031-6989(88)80674-X | 0.036 | |||
| 1979 | Kan WH, Farsang C, Preiksaitis HG, Kunos G. Affinity labelling of α-adrenoceptors in intact liver cells by [3H]phenoxybenzamine Biochemical and Biophysical Research Communications. 91: 303-311. PMID 229846 DOI: 10.1016/0006-291X(79)90618-1 | 0.035 | |||
| 2002 | Farsang C. ESH Scientific Newsletter Blood Pressure. 11: 190-191. DOI: 10.1080/080370502760050449 | 0.025 | |||
| 2002 | Farsang C. ESH Scientific Newsletter Blood Pressure. 11: 63-64. DOI: 10.1080/080370502753556987 | 0.025 | |||
| Hide low-probability matches. | |||||